Samenvatting
The present invention relates to recombinant variants of the human 4-hydroxyphenylpyruvate dioxygenase (HPD) enzyme that have a decreased sensitivity to an HPD inhibitor. The invention also relates to their use in clinical applications to treat tyrosine metabolism related diseases.
| Originele taal-2 | English |
|---|---|
| Octrooinummer | WO2024245986A |
| Status | Published - 2024 |
Vingerafdruk
Duik in de onderzoeksthema's van '4-hydroxyphenylpyruvate dioxygenase variants'. Samen vormen ze een unieke vingerafdruk.Citeer dit
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver